Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016.

Tytuł:
Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016.
Autorzy:
Araújo LO; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Nunes AMPB; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Ferreira VM; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Escola Bahiana de Medicina e Saúde, Salvador, Bahia, Brazil.
Cardoso CW; Secretaria Municipal de Saúde, Salvador, Bahia, Brazil.
Feitosa CA; Escola Bahiana de Medicina e Saúde, Salvador, Bahia, Brazil.
Reis MG; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.; Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Campos LC; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Bahia, Brazil.
Źródło:
PloS one [PLoS One] 2020 Sep 11; Vol. 15 (9), pp. e0238932. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Bordetella pertussis/*pathogenicity
Respiratory Tract Infections/*prevention & control
Whooping Cough/*epidemiology
Bordetella pertussis/isolation & purification ; Brazil/epidemiology ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Pertussis Vaccine/administration & dosage ; Respiratory Tract Infections/microbiology ; Retrospective Studies ; Time Factors ; Vaccination/methods ; Whooping Cough/microbiology ; Whooping Cough/prevention & control
References:
PLoS One. 2019 Jul 10;14(7):e0219534. (PMID: 31291359)
mBio. 2014 Apr 22;5(2):e01074. (PMID: 24757216)
Int J Environ Res Public Health. 2012 Dec;9(12):4626-38. (PMID: 23330226)
Vaccine. 2019 Aug 23;37(36):5414-5421. (PMID: 31331774)
BMJ Open. 2019 May 19;9(5):e025521. (PMID: 31110089)
Pediatrics. 2015 Oct;136(4):635-41. (PMID: 26347437)
Braz J Infect Dis. 2014 Mar-Apr;18(2):177-80. (PMID: 24275370)
J Pediatr (Rio J). 2015 Jul-Aug;91(4):333-8. (PMID: 25623040)
J Infect Dis. 2014 Apr 1;209 Suppl 1:S10-5. (PMID: 24158958)
Clin Infect Dis. 2015 Oct 1;61(7):1099-106. (PMID: 26082502)
Clin Infect Dis. 2015 Feb 1;60(3):333-7. (PMID: 25332078)
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S119-S122. (PMID: 27838663)
Rev Chilena Infectol. 2014 Aug;31(4):385-92. (PMID: 25327190)
J Biomed Inform. 2019 Jul;95:103208. (PMID: 31078660)
Hum Vaccin Immunother. 2020;16(1):61-69. (PMID: 31242082)
Emerg Infect Dis. 2017 Dec;23(13):. (PMID: 29155677)
Lancet. 2014 Oct 25;384(9953):1521-8. (PMID: 25037990)
J Pediatr (Rio J). 2016 Jan-Feb;92(1):40-5. (PMID: 26235829)
BMC Infect Dis. 2015 Oct 23;15:442. (PMID: 26498058)
An Pediatr (Engl Ed). 2018 Sep;89(3):170-175. (PMID: 29223471)
Pediatr Infect Dis J. 2015 Apr;34(4):444-5. (PMID: 25247586)
Pediatr Infect Dis J. 2015 May;34(5):513-9. (PMID: 25621762)
Epidemiol Infect. 2014 Apr;142(4):685-94. (PMID: 23406868)
BMC Infect Dis. 2016 Aug 17;16:422. (PMID: 27530444)
Front Immunol. 2019 Jul 03;10:1344. (PMID: 31333640)
Substance Nomenclature:
0 (Pertussis Vaccine)
Entry Date(s):
Date Created: 20200911 Date Completed: 20201102 Latest Revision: 20231112
Update Code:
20240105
PubMed Central ID:
PMC7485779
DOI:
10.1371/journal.pone.0238932
PMID:
32915869
Czasopismo naukowe
Pertussis, a severe respiratory infection caused by Bordetella pertussis, is distributed globally. Vaccination has been crucial to annual reductions in the number of cases. However, disease reemergence has occurred over the last decade in several countries, including Brazil. Here we describe the clinical and epidemiological aspects of suspected pertussis cases in Salvador, Brazil, and evaluate factors associated with case confirmation. This descriptive and retrospective study was conducted in the five hospitals in Salvador that reported the highest number of pertussis cases between 2011-2016. Demographic and clinical data were recorded for each patient. Bivariate analysis was performed to evaluate differences between groups (confirmed vs. unconfirmed cases) using Pearson's Chi-square test or Fisher's exact test. Results: Of 529 suspected pertussis cases, 29.7% (157/529) were confirmed by clinical, clinical-epidemiological or laboratory criteria, with clinical criteria most frequently applied (63.7%; 100/157). Unvaccinated individuals (43.3%; 68/157) were the most affected, followed by age groups 2-3 months (37.6%; 59/157) and <2 months (31.2%; 49/157). Overall, ≤50% of the confirmed cases presented a complete vaccination schedule. All investigated cases presented cough in association with one or more symptoms, especially paroxysmal cough (66.9%; 105/529) (p = 0.001) or cyanosis (66.2%; 104/529) (p<0.001). Our results indicate that pertussis occurred mainly in infants and unvaccinated individuals in Salvador, Brazil. The predominance of clinical criteria used to confirm suspected cases highlights the need for improvement in the laboratory tools used to perform rapid diagnosis. Fluctuations in infection prevalence demonstrate the importance of vaccination strategies in improving the control and prevention of pertussis.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies